Study on effect of Baoyuan Qiangshen Tablet No. I in prolongating interval of hemodialysis in patients of renal disease in terminal stagein prolongating interval of hemodialysis in patients of renal disease in terminal stage
Back to article page
|Updated:2021-08-27
|
Study on effect of Baoyuan Qiangshen Tablet No. I in prolongating interval of hemodialysis in patients of renal disease in terminal stagein prolongating interval of hemodialysis in patients of renal disease in terminal stage
Chinese Journal of Integrative MedicineVol. 3, Issue 1, Pages: 12-16(1997)
Affiliations:
Jiangsu Research Center of Nephrology -with TCM-,Zhenjiang,Jiangsu,WM
Zhu, BJ., Li, YS. Study on effect of Baoyuan Qiangshen Tablet No. I in prolongating interval of hemodialysis in patients of renal disease in terminal stagein prolongating interval of hemodialysis in patients of renal disease in terminal stage., CJIM 3, 12–16 (1997). https://doi.org/10.1007/BF02935427
Zhu Bi-Jiang, Li Yu-Sheng. Study on effect of Baoyuan Qiangshen Tablet No. I in prolongating interval of hemodialysis in patients of renal disease in terminal stagein prolongating interval of hemodialysis in patients of renal disease in terminal stage. [J]. Chinese Journal of Integrative Medicine 3(1):12-16(1997)
Zhu, BJ., Li, YS. Study on effect of Baoyuan Qiangshen Tablet No. I in prolongating interval of hemodialysis in patients of renal disease in terminal stagein prolongating interval of hemodialysis in patients of renal disease in terminal stage., CJIM 3, 12–16 (1997). https://doi.org/10.1007/BF02935427DOI:
Zhu Bi-Jiang, Li Yu-Sheng. Study on effect of Baoyuan Qiangshen Tablet No. I in prolongating interval of hemodialysis in patients of renal disease in terminal stagein prolongating interval of hemodialysis in patients of renal disease in terminal stage. [J]. Chinese Journal of Integrative Medicine 3(1):12-16(1997) DOI: 10.1007/BF02935427.
Study on effect of Baoyuan Qiangshen Tablet No. I in prolongating interval of hemodialysis in patients of renal disease in terminal stagein prolongating interval of hemodialysis in patients of renal disease in terminal stage
摘要
Objective: To evaluate the effect of Baoyuan Qiangshen Tablet No. I (BYQS)
a Chinese herbal medicine for reinforcing Kidney
activating circulation and eliminating evil Turbid factors
in prolongating interval of hemodialysis in patients of terminal stage of renal disease (TSRD).Methods: Twenty cases of TSRD were treated with BYQS combined with hemodialysis once every 5 days and the effect was observed and compared with control group treated with routine hemodialysis once every 3 days.Results: The increasing levels of serum creatinine
and blood urea nitrogen of BYQS group at dialysis interval were all lower than those of the control group (P < 0.01). After 3 months’ treatment
serum creatinine
blood urea nitrogen of BYQS group were lower than those before treatment
plasma albumin
lipoprotein
urine level of prostaglandin and anemia were all improved to various extent
but the creatinine clearance rate was unchanged. Conclusions: BYQS could prolong the interval and reduce the times of dialysis by way of regulating the lipid metabolic disorder
improving pathological change of kidney and protecting function of residual kidney unit. BYQS combined with hemodialysis is a good way of integrated traditional Chinese and Western medicine in treating TSRD.
Abstract
Objective: To evaluate the effect of Baoyuan Qiangshen Tablet No. I (BYQS)
a Chinese herbal medicine for reinforcing Kidney
activating circulation and eliminating evil Turbid factors
in prolongating interval of hemodialysis in patients of terminal stage of renal disease (TSRD).Methods: Twenty cases of TSRD were treated with BYQS combined with hemodialysis once every 5 days and the effect was observed and compared with control group treated with routine hemodialysis once every 3 days.Results: The increasing levels of serum creatinine
and blood urea nitrogen of BYQS group at dialysis interval were all lower than those of the control group (P < 0.01). After 3 months’ treatment
serum creatinine
blood urea nitrogen of BYQS group were lower than those before treatment
plasma albumin
lipoprotein
urine level of prostaglandin and anemia were all improved to various extent
but the creatinine clearance rate was unchanged. Conclusions: BYQS could prolong the interval and reduce the times of dialysis by way of regulating the lipid metabolic disorder
improving pathological change of kidney and protecting function of residual kidney unit. BYQS combined with hemodialysis is a good way of integrated traditional Chinese and Western medicine in treating TSRD.
关键词
terminal stage of renal diseaseBaoyuan Qiangshen tablet No. Ihemodialysis
Keywords
terminal stage of renal diseaseBaoyuan Qiangshen tablet No. Ihemodialysis